Soluble curcumin: A promising oral supplement for health management

Journal of Applied Pharmaceutical Science

Volumn 1, Issue 2, 2011, Pages 1-7

  Gandhi, Puneet ^a,b   Khan, Zeba ^a   Chakraverty, Nivedita ^a,b  

^a BHOPAL MEMORIAL HOSPITAL AND RESEARCH CENTRE   (India)

^b Career Institute of Medical Sciences   (India)

Author keywords

Bioavailability; Blood glucose; Lipid profile; Oral administration; Soluble curcumin

Indexed keywords

EID: 84873021731     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Alwi I., Santoso Teguh., Suyono S., Sutrisna B., Suyatna FD., Kresno SB., Ernie S. The Effect of Curcumin on Lipid Level in Patients with Acute Coronary Syndrome. Acta Med Indones 2008; 40: 201-210.
2. Anand P., Kunnumakkara AB., Newman RA., Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm 2007; 4: 807-818.
3. Anuchapreeda S., Tima S., Duangrat C., Limtrakul P. Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines. Cancer Chemother Pharmacol 2008; 62: 585-594.
4. Arun N., Nalini N. Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum Nutr 2002; 57: 41-52.
5. Bauma L., Cheunga SKK., Moka VCT., Lamb LCW., Leung VPY., Hui E., Ng CCY., Chowc M., Hoc PC., Lamc S., Woo J., Chiu HFK., Goggins W., Zee B., Wong A., Moka H., Chengf WKF., Fong C., Lee JSW., Chanh M-H., Szeto SSL., Lui VWC., Tsoh J., Kwok TCY., Chang HIS., Lamg CWK. Curcumin effects on blood lipid profile in a 6-month human study. Pharmacological Research 2007; 56: 509-514.
6. Bright JJ. Curcumin and autoimmune disease. Adv Exp Med Biol 2007; 595: 425-451.
7. Dhillon N., Aggarwal BB., Newman RA., Wolff RA., Kunnumakkara AB., Abbruzzese JL., Ng CS., Badmaev V., Kurzrock R. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 2008; 14: 4491-4499.
8. Inoue K., Nomura C., Ito S., Nagatsu A., Hino T., Oka H. Purification of curcumin, demethoxycurcumin, and bisdemethoxycurcumin by high-speed countercurrent chromatography. J Agric Food Chem 2008; 56: 9328-9336.
9. Jagadeesh MC., Sreepriya M., Bali G., Manjulakumari D. Biochemical studies on the effect of curcumin and embelin during Nnitrosodiethylamine/Phenobarbital induced-hepatocarcinogenesis in wistar rats. African Journal of Biotechnology 2009; 8: 4618-4622.
10. Jeong G-S., Oh G-S., Pae H-O., Jeong S-O., Kim Y-C., Shin MK., Seo BY., Han S., Lee HS., Jeong J-G., Koh J-S., Chung H-T. Comparative effects of curcuminoids on endothelial heme oxygenase-1 expression: ortho-methoxy groups are essential to enhance heme oxygenase activity and protection. Exp Mol Med 2006; 38: 393-400.
11. Jiao Y., Wilkinson J., Di X., Wang W., Hatcher H., Kock ND., D'Agostino R., Knovich MA., Torti FM., Torti SV. Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. Blood 2009; 113: 462-469.
12. Kidd PM. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev 2009; 14: 226-246.
13. Kim YS., Park HJ., Joo SY., Hong MH., Kim KH., Hong YJ., Kim JH., Park HW., Jeong MH., Cho JG., Park JC., Ahn YK. The Protective Effect of Curcumin on Myocardial Ischemia-Reperfusion Injury. Korean Circ J 2008; 38: 353-359.
14. Kumari P., Gupta MK., Ranjan R., Singh KK., Singh KK., Yadav R. Curcuma longa as feed additive in broiler birds and its pathophysiology effect. Indian J Exp Biol 2007; 45: 272-277.
15. Kurien BT., Scofield RH. Oral administration of heat-solubilized curcumin for potentially increasing curcumin bioavailability in experimental animals. Int J Cancer 2009; 125: 1992-1993.
16. Lin C-L., Lin J-K. Curcumin: a Potential Cancer Chemopreventive Agent through Suppressing NF-?B Signaling. J Cancer Mol 2008; 4: 11-16.
17. Mahfouz MM., Zhou SQ., Kummerow FA. Curcumin prevents the oxidation and lipid modification of LDL and its inhibition of prostacyclin generation by endothelial cells in culture. Prostaglandins & Other Lipid Mediat 2009; 90: 13-20.
18. Mayanglambam A., Dangelmaier CA., Thomas D., Reddy CD., Daniel JL., Kunapuli SP. Curcumin inhibits GPVI-mediated platelet activation by interfering with the kinase activity of Syk and the subsequent activation of PLCgamma2. Platelets 2010; 21: 211-220.
19. Mishra S., Palanivelu K. The effect of curcumin (turmeric) on Alzheimer's disease: An overview. Ann Indian Acad Neurol 2008; 11: 13-19.
20. Nair HB., Sung B., Yadav VR., Kannappan R., Chaturvedi MM., Aggarwal BB. Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem Pharmacol 2010; 80: 1833-1843.
21. Pari L., Amali RD. Protective of Tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine induced hepatotoxicity in rats. J Pharm Pharmaceut Sci 2005; 8: 115-123.
22. Park C., Moon DO., Choi IW., Choi BT., Nam TJ., Rhu CH., Kwon TK., Lee WH., Kim GY., Choi YH. Curcumin induces apoptosis and inhibits prostaglandin E(2) production in synovial fibroblasts of patients with rheumatoid arthritis. Int J Mol Med 2007; 20: 365-372.
23. Rajesh P., Balasubramaniam V., Ramesh N., Rajesh V., Kannan A. A biochemical approach on Curcuma longa Linn. (Turmeric) against Alcoholic liver diseases by using Swiss Albino mice and SDS-PAGE analysis. Int J Med Res 2010; 1: 6-17.
24. Rungseesantivanon S., Thenchaisri N., Ruangvejvorachai P., Patumraj S. Curcumin supplementation could improve diabetesinduced endothelial dysfunction associated with decreased vascular superoxide production and PKC inhibition. Complementary and Alternative Medicine 2010; 10: 1-57.
25. Sandur SK., Ichikawa H., Pandey MK., Kunnumakkara AB., Sung B., Sethi G., Aggarwal BB. Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med 2007; 43: 568-580.
26. Sharma S., Kulkarni SK., Chopra K. Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 2006; 33: 940-945.
27. Shishodia S., Singh T., Chaturvedi MM. Modulation of transcription factors by curcumin. Adv Exp Med Biol 2007; 595: 127-148.
28. Tirkey N., Kaur G., Vij G., Chopra K. Curcumin, a diferuloylmethane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidneys. BMC Pharmacology 2005; 5: 1-15.
29. Wickenberg J., Ingemansson SL., Hlebowicz J. Effects of Curcuma longa (turmeric) on postprandial plasma glucose and insulin in healthy subjects. Nutrition Journal 2010; 9: 1-143.
30. Yuan H-y., Kuang S-y., Zheng X., Ling H-y., Yang Y-B., Yan P-K., Li K., Liao D-F. Curcumin inhibits cellular cholesterol accumulation by regulating SREBP-1/caveolin-1 signaling pathway in vascular smooth muscle cells. Acta Pharmacologica Sinica 2008; 29: 555-563.